Projects per year
Fingerprint
Dive into the research topics where Lawrence Wagman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Finished
-
PRIMARY BREAST CANCER THERAPY GROUP - NSABP
Wagman, L. (PI) & Terz, J. J. (CoPI)
04/1/87 → 01/31/92
Project: Research
-
SURGICAL ONCOLOGY
Wagman, L. (PI), Beatty, J. D. (CoPI) & Benfield, J. J. R. (CoPI)
09/1/85 → 06/30/94
Project: Research
-
ASO Visual Abstract: Practice Patterns of Graduates from a Surgical Oncology Fellowship Program
Scott, A., Nguyen, A., Perez, C., Wagman, L. D., Melstrom, K., Fong, Y., Melstrom, L. & Lai, L. L., Jun 1 2026, In: Annals of Surgical Oncology. 33, 6, p. 4957 1 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Practice Patterns of Graduates from a Surgical Oncology Fellowship Program
Scott, A., Nguyen, A., Perez, C., Wagman, L. D., Melstrom, K., Fong, Y., Melstrom, L. & Lai, L. L., Jun 2026, In: Annals of Surgical Oncology. 33, 6, p. 4940-4948 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Enhancing diversity in oncology trials: Key strategies from the ACORI community oncology inclusive clinical trial design summit.
Demirhan, K., Beg, S., Benson, A. B., Black, L., Kisiel, M., Lacy, M. M., Myles, J., Pal, S. K., Plotkin, E., Wagman, L. D. & Shivakumar, L., Jun 2025, In: Journal of Clinical Oncology. 43, p. e23027-e23027Research output: Contribution to journal › Article › peer-review
-
Reduced Floxuridine Dose Limits Hepatobiliary Toxicity Without Negatively Impacting Survival After Resection of Colorectal Cancer Liver Metastases
Labadie, K. P., Fan, D., Dominguez, D. A., Wong, P., Meshkin, E., Vien, P., Lau, S. C., Kessler, J., Wagman, L. D., Fong, Y., Fakih, M. G. & Melstrom, L. G., Dec 2025, In: Annals of Surgical Oncology. 32, 13, p. 9526-9533 8 p.Research output: Contribution to journal › Article › peer-review
Open Access -
NSABP FC-6: Surgical conversion rate in colorectal cancer patients with unresectable, KRAS wild-type liver metastases receiving mFOLFOX7 plus cetuximab
NSABP FC-6 Study Group, Dec 15 2022, In: Journal of Surgical Oncology. 126, 8, p. 1494-1503 10 p.Research output: Contribution to journal › Article › peer-review